Eam Investors, LLC Neu Base Therapeutics, Inc. Transaction History

Eam Investors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$7.25 - $9.71 $624,036 - $835,778	-86,074 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$6.69 - $11.51 $120,011 - $206,477	-17,939 Reduced 17.25%	86,074 $756,000
Q1 2020 May 13, 2020	BUY	$4.77 - $8.23 $19,805 - $34,170	4,152 Added 4.16%	104,013 $741,000
Q4 2019 Feb 11, 2020	BUY	$4.5 - $8.1 $449,374 - $808,874	99,861 New	99,861 $719,000

Ticker NBSE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,258,700
Description
NeuBase Therapeutics, Inc., a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as ...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.